about
Novel therapeutic targets for pancreatic cancerRole of bile acids in carcinogenesis of pancreatic cancer: An old topic with new perspective.Therapeutic potential of targeting acinar cell reprogramming in pancreatic cancerβ-arrestin2/miR-155/GSK3β regulates transition of 5'-azacytizine-induced Sca-1-positive cells to cardiomyocytesProteomic identification of microRNA-122a target proteins in hepatocellular carcinoma.Functional interplay between CBP and PCAF in acetylation and regulation of transcription factor KLF13 activity.Revisit complexation between DNA and polyethylenimine - Effect of uncomplexed chains free in the solution mixture on gene transfection.Ubiquitous expression of MAKORIN-2 in normal and malignant hematopoietic cells and its growth promoting activity.Biotransformation and in vitro metabolic profile of bioactive extracts from a traditional Miao-nationality herbal medicine, Polygonum capitatum.A small-molecule modulator of the tumor-suppressor miR34a inhibits the growth of hepatocellular carcinoma.Effect of Berberine on promoting the excretion of cholesterol in high-fat diet-induced hyperlipidemic hamstersSmall and Long Non-Coding RNAs: Novel Targets in Perspective Cancer Therapy.Hepatitis C virus NS5A protein cooperates with phosphatidylinositol 4-kinase IIIα to induce mitochondrial fragmentation.Small molecule targeting miR-34a for cancer therapy.TRPC5 channels participate in pressure-sensing in aortic baroreceptors.G protein-coupled estrogen receptor inhibits the P2Y receptor-mediated Ca(2+) signaling pathway in human airway epithelia.Targeting EZH2 for cancer therapy: progress and perspective.HIV-1 gp120 primes lymphocytes for opioid-induced, beta-arrestin 2-dependent apoptosisB cell CLL/lymphoma 6 member B inhibits hepatocellular carcinoma metastases in vitro and in mice.Marine natural products with anti-inflammatory activity.EZH2 coupled with HOTAIR to silence MicroRNA-34a by the induction of heterochromatin formation in human pancreatic ductal adenocarcinoma.Epigenetic silencing of miR-490-3p reactivates the chromatin remodeler SMARCD1 to promote Helicobacter pylori-induced gastric carcinogenesis.Hepatitis B virus X protein promotes hepatocellular carcinoma transformation through interleukin-6 activation of microRNA-21 expression.High level virion production and surface antigen expression with 1.5 copies of hepatitis B viral genome.Insight Into the Role of Long Noncoding RNA in Cancer Development and Progression.Truncated HBx-dependent silencing of GAS2 promotes hepatocarcinogenesis through deregulation of cell cycle, senescence and p53-mediated apoptosis.Inhibition of bone morphogenic protein 4 restores endothelial function in db/db diabetic mice.Diagnostic Potential of lncRNAs in Cancer.Role of microRNA-95 in the anticancer activity of Brucein D in hepatocellular carcinoma.Identification of metabolites of FR429, a potential antitumor ellagitannin, transformed by rat intestinal bacteria in vitro, based on liquid chromatography-ion trap-time of flight mass spectrometry analysis.Identification of Small Molecule Modulators of MicroRNA by Library Screening.In Vivo Metabolite Profiling of a Purified Ellagitannin Isolated from Polygonum capitatum in Rats.Berberine induces miR-373 expression in hepatocytes to inactivate hepatic steatosis associated AKT-S6 kinase pathway.Author Correction: TRPC5 channels participate in pressure-sensing in aortic baroreceptors.High expression of EZH2 is associated with tumor aggressiveness and poor prognosis in patients with esophageal squamous cell carcinoma treated with definitive chemoradiotherapyClinical significance of exosomes as potential biomarkers in cancerActivation of PTEN by inhibition of TRPV4 suppresses colon cancer developmentBone morphogenic protein-4 induces endothelial cell apoptosis through oxidative stress-dependent p38MAPK and JNK pathway
P50
Q24564267-45D74605-3AB1-44D5-8752-FD027472F296Q27693345-38071887-A8BB-45E8-9041-07EBED9ECBCAQ28068998-29B6BF5B-3F3E-4CD7-8104-B7DE2732F6C9Q28590593-382D043F-8D51-4471-879B-2A7F2887D324Q30989557-B79FF72E-E78D-4D4B-8DBB-C73C03084278Q33598638-2C715E19-720F-4C21-8B26-0D05289549DDQ33740338-CA87349A-8A13-4EB0-AF90-90ED6206B533Q35133515-FBF5ED5E-B3FA-405A-9717-38CDA9C762FCQ35208174-32CF5979-617B-45DE-ABA1-0C3CE262F557Q35251019-1A0195D2-D251-4C9F-B202-32F7E01F8AA7Q35996941-F2B03322-FDBC-4A0E-BFA2-C34B6103B1FFQ36608200-25413686-9CB3-4D7C-B9B5-33D1AF25F9B0Q36724694-27F3635D-B974-421D-90EB-AB0A7C55B35CQ36997827-2A5B475F-89AF-4050-9D6A-2C2D9385CCF0Q37099484-DF06D275-F14C-42D1-AC23-FA16D488E096Q37110316-9AA8B2DC-9447-42BC-956A-6F5B36343AF7Q37204063-F7481FF9-C0BB-4713-A0B6-1EE150BFEC53Q37277318-C5AE0867-AF71-41A6-9538-345C345D72DBQ38304242-2B494047-2AE3-4783-94EB-C6807AE544FBQ38681602-67CD8169-6916-46A8-811D-BE87BC21D552Q38748250-0A0F4D66-6C31-4458-9675-CA5A38BA12ABQ38928834-84DDEA72-B500-434D-BF61-3B023905B59CQ38969242-FAAB82E0-19D9-404F-A5D3-E3EC9480C932Q39843779-43DD9992-630D-4EEB-B7FA-6E266A70BB87Q40559518-C8EDFB7C-B1A4-441B-B6FE-7B0CBD2E51ABQ41272310-6B2D402D-7C41-4F75-804C-916877A69A43Q42257195-A471D6C4-A056-4CDB-A220-CC7C2358074AQ42270223-A68DAAA4-4835-4CE8-8C12-F8770643DA1FQ46915980-ABB909E9-4954-4366-9966-0B91FA83FA53Q47182022-A0E93AC7-46E6-4214-A53A-54AEE23B0DD9Q51282058-A3B4B282-8685-47E4-9766-9E395D6EE9AEQ51837308-3C3EFC4A-A637-487A-BEFD-3EB5746D50F7Q52686854-0302BE3A-4AB4-48BA-8F66-F83BEB946327Q54941582-2E591BE6-B6A7-4A8F-996B-D3CDD6D4197DQ58321557-D54F43AD-C32A-4DD3-9643-AFE713377E33Q61443542-C2026BC0-DC0C-4038-8AD1-DB5B31059E38Q92690681-1EBA41DD-3E61-4520-BE41-F291112DB7C3Q95410251-5AFD58F9-4460-4B4F-B86D-CB14DA9B10CB
P50
description
researcher ORCID ID = 0000-0002-0249-3414
@en
wetenschapper
@nl
name
Yangchao Chen
@ast
Yangchao Chen
@en
Yangchao Chen
@es
Yangchao Chen
@nl
type
label
Yangchao Chen
@ast
Yangchao Chen
@en
Yangchao Chen
@es
Yangchao Chen
@nl
prefLabel
Yangchao Chen
@ast
Yangchao Chen
@en
Yangchao Chen
@es
Yangchao Chen
@nl
P31
P496
0000-0002-0249-3414